363 related articles for article (PubMed ID: 27840358)
1. A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis.
Trianto HB; Wardhani SO
Acta Med Indones; 2016 Jul; 48(3):221-227. PubMed ID: 27840358
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
Adam Z; Pour L; Krejčí M; Ševčíková S; Pourová E; Ševčíková E; Král Z; Mayer J
Vnitr Lek; 2016 Jan; 62(1):25-39. PubMed ID: 26967234
[TBL] [Abstract][Full Text] [Related]
3. Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report.
Kim YL; Gong SJ; Hwang YH; Joo JE; Cho YU; Lee JA; Sung SA; Lee SY; Kim NY
J Korean Med Sci; 2011 Jun; 26(6):824-8. PubMed ID: 21655071
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment with CHOP therapy for progressive of primary macroglobulinemia without further increase of serum IgM].
Wakimoto N; Misumi M; Maeda T; Shimada T; Wakao D; Sato Y; Takahashi N; Sugahara Y; Yoshida K; Yagasaki F; Ito Y; Nakamura Y; Kawai N; Matsuda A; Jinnai I; Bessho M
Rinsho Ketsueki; 2005 Jul; 46(7):536-8. PubMed ID: 16440749
[TBL] [Abstract][Full Text] [Related]
6. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
7. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
[TBL] [Abstract][Full Text] [Related]
8. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia.
Buske C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenström's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Kawano N; Ikeda N; Yoshida S; Sugio Y; Yamashita K; Uezono S; Hayashi T; Hara S; Makino S; Shimoda K; Ueda A
Int J Hematol; 2010 Sep; 92(2):391-7. PubMed ID: 20686877
[TBL] [Abstract][Full Text] [Related]
10. [Osteonecrosis developing after rituximab-containing chemotherapy for Waldenström macroglobulinemia].
Nakamura F; Hirai R; Higo T; Togano T; Sekine R
Rinsho Ketsueki; 2018; 59(3):305-309. PubMed ID: 29618689
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
[TBL] [Abstract][Full Text] [Related]
12. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of refractory cold hemagglutinemia in MYD88 L265P mutation-negative Waldenström's macroglobulinemia with bortezomib.
Izumi M; Tsunemine H; Suzuki Y; Tomita A; Kusumoto T; Kodaka T; Itoh K; Takahashi T
Int J Hematol; 2015 Aug; 102(2):238-43. PubMed ID: 25794560
[TBL] [Abstract][Full Text] [Related]
14. [MALT lymphoma accompanied by elevated serum IgM levels mimicking Waldenström's macroglobulinemia].
Izumi S; Kimura K; Takeda Y; Tsukamoto S; Yamazaki M; Mishina T; Nagai Y; Takaishi K; Nagao Y; Oshima-Hasegawa N; Mitsukawa S; Mimura N; Takeuchi M; Ohwada C; Iseki T; Ota S; Nakaseko C; Sakaida E
Rinsho Ketsueki; 2018; 59(12):2600-2605. PubMed ID: 30626796
[TBL] [Abstract][Full Text] [Related]
15. Management of Waldenström Macroglobulinemia in Limited-Resource Settings.
Riva E; Tietsche de Moraes Hungría V; Chiattone C; Martínez-Cordero H
Hematol Oncol Clin North Am; 2023 Aug; 37(4):801-807. PubMed ID: 37258356
[TBL] [Abstract][Full Text] [Related]
16. [Follicular lymphoma complicated with myelofibrosis and macroglobulinemia at initial presentation].
Kuroda H; Abe T; Jomen W; Yoshida M; Matsuno T; Sato M; Yamada M; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Murase K; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2068-73. PubMed ID: 24305541
[TBL] [Abstract][Full Text] [Related]
17. The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
Buske C; Hoster E; Dreyling M; Eimermacher H; Wandt H; Metzner B; Fuchs R; Bittenbring J; Woermann B; Hohloch K; Hess G; Ludwig WD; Schimke J; Schmitz S; Kneba M; Reiser M; Graeven U; Klapper W; Unterhalt M; Hiddemann W;
Leukemia; 2009 Jan; 23(1):153-61. PubMed ID: 18818699
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations of Waldenström macroglobulinemia.
Baehring JM; Hochberg EP; Raje N; Ulrickson M; Hochberg FH
Nat Clin Pract Neurol; 2008 Oct; 4(10):547-56. PubMed ID: 18813229
[TBL] [Abstract][Full Text] [Related]
19. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
Treon SP; Gertz MA; Dimopoulos M; Anagnostopoulos A; Blade J; Branagan AR; Garcia-Sanz R; Johnson S; Kimby E; Leblond V; Fermand JP; Maloney DG; Merlini G; Morel P; Morra E; Nichols G; Ocio EM; Owen R; Stone MJ
Blood; 2006 May; 107(9):3442-6. PubMed ID: 16410453
[TBL] [Abstract][Full Text] [Related]
20. [Myelopathy manifesting as macroglobulinemia].
Woimant F; Schanen A; Bertail MA; Dupuy M; Lecoz P; Haguenau M; Pépin B
Ann Med Interne (Paris); 1985; 136(2):121-4. PubMed ID: 3935023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
